Format

Send to

Choose Destination
Kidney Int. 2016 May;89(5):985-987. doi: 10.1016/j.kint.2016.02.020.

Epidermal growth factor and kidney disease: a long-lasting story.

Author information

1
Institut National de la Santé et de la Recherche Médicale (INSERM), U1048, Institute of Cardiovascular and Metabolic Disease, Toulouse, France; Université Toulouse III Paul-Sabatier, Toulouse, France.
2
Institut National de la Santé et de la Recherche Médicale (INSERM), U1048, Institute of Cardiovascular and Metabolic Disease, Toulouse, France; Université Toulouse III Paul-Sabatier, Toulouse, France. Electronic address: joost-peter.schanstra@inserm.fr.

Abstract

Epidermal growth factor has been previously associated with kidney disease. In this issue of Kidney International, Betz et al. (2016) link urinary epidermal growth factor abundance with an increased risk of the development of diabetic nephropathy in a novel animal model of diabetic nephropathy and in a large cohort of patients with type 2 diabetes. Although the clinical value of these observations needs to be confirmed in further studies, these observations further strengthen the tight link between epidermal growth factor and kidney disease.

PMID:
27083276
DOI:
10.1016/j.kint.2016.02.020
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center